Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx.

dc.contributor.author

Wang, Chengyuan

dc.contributor.author

Sturgis, Erich M

dc.contributor.author

Chen, Xingming

dc.contributor.author

Zheng, Hongliang

dc.contributor.author

Wei, Qingyi

dc.contributor.author

Li, Guojun

dc.date.accessioned

2019-02-01T15:22:21Z

dc.date.available

2019-02-01T15:22:21Z

dc.date.issued

2016-05

dc.date.updated

2019-02-01T15:22:17Z

dc.description.abstract

Functional polymorphisms of miRNAs may affect the function and target expression of miRNAs, which can, in turn, affect the biological activity, etiology, and prognosis of cancer. We hypothesized that four common polymorphisms in pre-miRNAs (hsa-mir-146a rs2910164 G > C, hsa-mir-196a2 rs11614913 C > T, hsa-mir-149 rs2292832 G > T, and hsa-mir-499 rs3746444 A > G) are associated with survival in SCCNOP. We used univariate and multivariable Cox models to evaluate the associations between the four polymorphisms and survival. We found that hsa-mir-149 rs2292832 and hsa-mir-499 rs3746444 had statistically significant associations with survival, but hsa-mir-146a rs2910164 and hsa-mir-196a2 rs11614913 did not. Patients having the hsa-mir-149 CC and hsa-mir-499 TT wild-type genotypes had significantly better overall, disease-specific, and disease-free survival compared with those who had the corresponding variant CT/TT and CT/CC genotypes, respectively. Furthermore, these genotypes were significantly associated with reduced risk of overall death, death owing to disease, and recurrence after adjustment for important prognostic confounders, indicating that these pre-miRNA polymorphisms may be prognostic biomarkers for SCCNOP. Moreover, the stratified analyses based on smoking status and treatment indicated that the effects of hsa-mir-149 and hsa-mir-499 polymorphisms on survival were more pronounced in ever smokers and patients treated with chemoradiation. Our findings support that the hsa-mir-149 rs2292832 and hsa-mir-499 rs3746444 polymorphisms play a significant role in the prognosis of SCCNOP, especially in smokers and patients treated with chemoradiation. Prospective studies with larger sample sizes are needed to confirm these findings.

dc.identifier

8512

dc.identifier.issn

1949-2553

dc.identifier.issn

1949-2553

dc.identifier.uri

https://hdl.handle.net/10161/18004

dc.language

eng

dc.publisher

Impact Journals, LLC

dc.relation.ispartof

Oncotarget

dc.relation.isversionof

10.18632/oncotarget.8512

dc.subject

Humans

dc.subject

Carcinoma, Squamous Cell

dc.subject

Head and Neck Neoplasms

dc.subject

Genetic Predisposition to Disease

dc.subject

MicroRNAs

dc.subject

Prognosis

dc.subject

Disease-Free Survival

dc.subject

Proportional Hazards Models

dc.subject

Genotype

dc.subject

Polymorphism, Single Nucleotide

dc.subject

Adult

dc.subject

Aged

dc.subject

Middle Aged

dc.subject

Female

dc.subject

Male

dc.subject

Kaplan-Meier Estimate

dc.subject

Biomarkers, Tumor

dc.title

Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx.

dc.type

Journal article

duke.contributor.orcid

Wei, Qingyi|0000-0002-3845-9445

pubs.begin-page

26444

pubs.end-page

26453

pubs.issue

18

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Population Health Sciences

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Medicine, Medical Oncology

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

7

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx.pdf
Size:
3.74 MB
Format:
Adobe Portable Document Format